Friday 4th September 2009 |
Text too small? |
Investment Research Group, the investment advisory and brokerage firm, sold a further 1.1 million shares, completing its capital raising a day after Tony Falkenstein injected $400,000 into the business.
IRG, which resumed trading on the NZAX this week after being suspended last month for filing a late annual report, placed the shares with an existing shareholder at 2.25 cents apiece, raising about $25,000. Yesterday, Falkenstein’s Edwin Trust acquired 17.8 million shares, subject to shareholder approval.
Last month IRG’s bank granted a waiver to a covenant breach and confirmed it will continue its funding support for the company. At the time, managing director Brent King said the company aimed to raise about $500,000 to bolster its balance sheet. The shares, which trade infrequently, soared some 91% to 2 cents today, valuing the company at $1.18 million. They have tumbled 86% in the past 12 months, having traded at 7 cents last September.
“We’ve been surprised and are very pleased with the support from shareholders” since the bank accepted IRG’s definition of capital ratios in August, King told BusinessWire.
“We haven’t just stabilised, we’re aggressively placed” to take advantage of an expected correction in the markets, he said. IRG will look to take advantage of good deals when they arise, King said.
Businesswire.co.nz
No comments yet
IRG sells Auckland advisory business to Forsyth Barr
IRG full-year loss widens to $1.1 mln as costs rise; assets under review
IRG to sell assets, retain listed shell, King mulls bid
IRG advising second company on potential NZ listing
Investment Research Group posts first-half loss, predicts better second half
IRG acquires Sharechat
IRG suspended on overdue full-year accounts
Investment Research Group borrows money off CEO, talks to banks about trimming payments
IRG to seek cash injection via rights issue
IRG resolves bank covenant breach row